|
1
|
Schoen RE: The case for population-based
screening for colorectal cancer. Nat Rev Cancer. 2:65–70. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fleischhacker M and Schmidt B: Circulating
nucleic acids (CNAs) and cancer – a survey. Biochim Biophys Acta.
1775:181–232. 2007.
|
|
3
|
Leon SA, Shapiro B, Sklaroff DM and Yaros
MJ: Free DNA in the serum of cancer patients and the effect of
therapy. Cancer Res. 37:646–650. 1977.PubMed/NCBI
|
|
4
|
Shapiro B, Chakrabarty M, Cohn EM and Leon
SA: Determination of circulating DNA levels in patients with benign
or malignant gastrointestinal disease. Cancer. 51:2116–2120. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Silva JM, Rodriguez R, Garcia JM, Muñoz C,
Silva J, Dominguez G, Provencio M, España P and Bonilla F:
Detection of epithelial tumour RNA in the plasma of colon cancer
patients is associated with advanced stages and circulating tumour
cells. Gut. 50:530–534. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Silva J, Silva JM, Garcia JM, Dominguez G
and Bonilla F: RNA is more sensitive than DNA in identification of
breast cancer patients bearing tumor nucleic acids in plasma. Gene
Chromosome Cancer. 3:375–376. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Silva JM, Dominguez G, Silva J, Garcia JM,
Sanchez A, Rodriguez O, Provencio M and Bonilla F: Detection of
epithelial messenger RNA in the plasma of breast cancer patients is
associated with poor prognosis tumor characteristics. Clin Cancer
Res. 7:2821–2825. 2001.PubMed/NCBI
|
|
8
|
Dasi F, Lledo S, Garcia-Granero E, Ripoll
R, Marugan M, Tormo M, Garcia-Conde J and Aliño SF: Real-time
quantification in plasma of human telomerase reverse transcriptase
(hTERT) mRNA: a simple blood test to monitor disease in cancer
patients. Lab Invest. 81:767–769. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong SC, Lo SF, Cheung MT, Ng KO, Tse CW,
Lai BS, Lee KC and Lo YM: Quantification of plasma catenin mRNA in
colorectal cancer and adenoma patients. Clin Cancer Res.
10:1613–1617. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garcia V, Garcia JM, Peña C, Silva J,
Dominguez G, Lorenzo Y, Diaz R, Espinosa P, Garcia de Sola J,
Cantos B and Bonilla F: Free circulating mRNA in plasma from breast
cancer patients and clinical outcome. Cancer Lett. 263:312–320.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garcia V, Garcia JM, Peña C, Silva J,
Dominguez G, Hurtado A, Alonso I, Rodriguez R, Provencio M and
Bonilla F: Thymidylate synthase mRNA expression in plasma from
colon cancer patients. Clin Cancer Res. 12:2095–2100. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Collado M, Garcia V, Garcia JM, Alonso I,
Lombardia L, Diaz-Uriarte R, Fernandez Luis Lopez, Zaballos A,
Bonilla F and Serrano M: Genomic profiling of circulating plasma
RNA for the analysis of cancer. Clin Chem. 53:1860–1863. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pilarsky C, Wenzig M, Specht T, Saeger HD
and Grutzmann R: Identification and validation of commonly
overexpressed genes in solid tumors by comparison of microarray
data. Neoplasia. 6:744–750. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
Large-scale meta-analysis of cancer microarray data identifies
common transcriptional profiles of neoplastic transformation and
progression. Proc Natl Acad Sci USA. 101:9309–9314. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoshimura H, Dhar DK, Kohno H, Kubota H,
Fujii T, Ueda S, Kinugasa S, Tachibana M and Nagasue N: Prognostic
impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal
cancer patients: correlation with tumor angiogenesis and
cyclooxygenase-2 expression. Clin Cancer Res. 10:8554–8560. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saville MK, Sparks A, Xirodimas DP,
Wardrop J, Stevenson LF, Bourdon JC, Woods YL and Lane DP:
Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in
vivo. J Biol Chem. 279:42169–42181. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gonen H, Bercovich B, Orian A, Carrano A,
Takizawa C, Yamanaka K, Pagano M, Iwai K and Ciechanover A:
Identification of the ubiquitin carrier proteins, E2s, involved in
signal-induced conjugation and subsequent degradation of
IkappaBalpha. J Biol Chem. 74:14823–14830. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Garcia JM, Garcia V, Peña C, Dominguez G,
Silva J, Diaz R, Espinosa P, Citores MJ, Collado M and Bonilla F:
Extracellular plasma RNA from colon cancer patients is confined in
a vesicle-like structure and is mRNA-enriched. RNA. 14:1424–1432.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Al-Nedawi K, Meehan B, Micallef J, Lhotak
V, May L, Guha A and Rak J: Intercellular transfer of the oncogenic
receptor EGFRvIII by microvesicles derived from tumor cells. Nat
Cell Biol. 10:619–624. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Skog J, Würdinger T, van Rijn S, Meijer
DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky
AM and Breakefield XO: Gliobastoma microvesicles transport RNA and
proteins that promote tumor growth and provide diagnostic
biomarkers. Nat Cell Biol. 10:1470–1476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hasselmann DO, Rappl G, Rossler M, Ugurel
S, Tilgen W and Reinhold U: Detection of tumor-associated
circulating mRNA in serum, plasma and blood cells from patients
with disseminated malignant melanoma. Oncol Res. 8:115–118.
2001.PubMed/NCBI
|
|
23
|
Kopreski MS, Benko FA and Gocke CD:
Circulating RNA as a tumor messenger in the serum of patient of
malignant melanoma. Clin Cancer Res. 5:1961–1965. 1999.
|
|
24
|
Duffy MJ, van Dalen A, Haglund C, Hansson
L and Kalapdor R: Clinical utility of biochemical markers in
colorectal cancer: European Group on tumor markers (EGTM). Eur J
Cancer. 39:718–727. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bertout JA, Patel SA and Simon MC: The
impact of O2 availability on human cancer. Nat Rev
Cancer. 8:967–975. 2008.
|
|
26
|
Wouters BG and Koritzinsky M: Hypoxia
signaling through mTOR and the unfolded protein response in cancer.
Nat Rev Cancer. 8:851–864. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Erler JT, Bennewith KL, Nicolau M,
Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS and Giaccia AJ:
Lysyl oxidase is essential for hypoxia-induced metastasis. Nature.
440:1222–1226. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Flamme I, Krieg M and Plate KH:
Up-regulation of vascular endothelial growth factor in stromal
cells of hemangioblastomas is correlated with up-regulation of the
transcription factor HRF/HIF-2alpha. Am J Pathol. 153:25–29. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Talks KL, Turley H, Gatter KC, Maxwell PH,
Pugh CW, Ratcliffe PJ and Harris AL: The expression and
distribution of the hypoxia-inducible factors HIF-1alpha and
HIF-2alpha in normal human tissues, cancers, and tumor-associated
macrophages. Am J Pathol. 157:411–421. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Baba Y, Nosho K, Shima K, Irahara N, Chan
AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS and Ogino S:
HIF1A overexpression is associated with poor prognosis in a cohort
of 731 colorectal cancers. Am J Pathol. 176:2292–2301. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rasheed S, Harris AL, Tekkis PP, Turley H,
Silver A, McDonald PJ, Talbot IC, Glynne-Jones R, Northover JM and
Guenther T: Hypoxia-inducible factor-1α and -2α are expressed in
most rectal cancers but only hypoxia-inducible factor-1 α is
associated with prognosis. Br J Cancer. 100:1666–1673. 2009.
|
|
32
|
Yoshimura H, Dhar DK, Kohno H, Kubota H,
Fujii T, Ueda S, Kinugasa S, Tachibana M and Nagasue N: Prognostic
impact of hypoxia-inducible factors 1α and 2α in colorectal cancer
patients: correlation with tumor angiogenesis and cyclooxygenase-2
expression. Clin Cancer Res. 10:8554–8560. 2004.
|
